JNX0.F Therma Bright Inc.
- Market cap
- EUR 245K
- P/E
- -
- P/B
- 3.99x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2026.
Is JNX0.F undervalued?
Graham numberThe Graham number of Therma Bright Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Therma Bright Inc. fundamental analysis
No fundamental analysis for Therma Bright Inc. yet.
Therma Bright Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Therma Bright Inc.
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therap…
Full company profileTherma Bright Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Apr 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Therma Bright Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 139K | 23.9K | 26.1K | 80.3K | 119K |
| Gross Profit | 63.5K | 23.9K | 25.5K | 54.9K | 89.7K |
| Operating Income | -5.84M | -3.68M | -1.23M | -1.77M | -1.03M |
| EBITDA | -5.73M | -3.68M | -2.34M | -4.25M | -1.03M |
| Net Income | -5.88M | -3.77M | -2.45M | -4.34M | -1.04M |
| EPS | -0.02 | -0.01 | -0.01 | -0.07 | -0.02 |
| Balance Sheet | |||||
| Total Assets | 4.00M | 2.21M | 3.19M | 249K | 218K |
| Total Liabilities | 1.25M | 2.16M | 1.87M | 1.81M | 2.15M |
| Shareholders' Equity | 2.75M | 44.8K | 1.32M | -1.57M | -1.93M |
| Cash & Short-term Investments | 3.08M | 182K | 1.10K | 1.47K | 1.84K |
| Cash Flow | |||||
| Operating Cash Flow | -3.80M | -2.17M | -1.01M | -147K | -239K |
| Capital Expenditure | 0.00 | 268K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -3.80M | -2.44M | -1.01M | -147K | -239K |
| Ratios | |||||
| ROE | -214.1% | -8,411.7% | -185.1% | - | - |
| ROA | -147.0% | -170.5% | -76.8% | -1,746.3% | -478.9% |
| Net Profit Margin | -4,218.0% | -15,765.4% | -9,402.8% | -5,410.4% | -874.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Therma Bright Inc. dividends
Therma Bright Inc. has not paid dividends in the last 4 fiscal years.
Last stock split: 1:8 on Jul 8, 2025.
Who owns Therma Bright Inc.
- Insiders 12.68%
- Institutions 0.00%
- Public & others 87.32%
- Shares outstanding 61.2M
- Free float 53.3M
Therma Bright Inc. company profile
- Company name
- Therma Bright Inc.
- Ticker
- JNX0.F
- ISIN
- CA8834262070
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- July
- Address
- 345 Danforth Avenue, Toronto, ON, Canada, M4K 1N7
- Website
- thermabright.com
About Therma Bright Inc.
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. The company also offers Inretio, a medical device for ischemic stroke treatment; Digital Cough Test (DCT), an app that uses artificial intelligence to detect multiple respiratory diseases; and inhaled statin therapy for the treatment of COVID-19 pneumonia and acute respiratory distress syndrome in hospitalized patients. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.
Therma Bright Inc. management
3- Mr. Roberto Fia C.F.A.Chairman, President & CEO · born 1970
- Mr. Sung Min Myung C.A., CPAChief Financial Officer · born 1986
- Mr. Michael MayoDirector of Sales